# OnCo record paper-monarche-jco-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-monarche-jco-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-monarche-jco-2020" ;
  schema:name "monarchE: two years of abemaciclib after surgery in high-risk, hormone-receptor-positive early breast cancer"@en ;
  schema:description "Adding two years of the CDK4/6 inhibitor abemaciclib to standard hormone therapy after surgery cut the risk of the cancer coming back by a quarter in women with node-positive, high-risk disease."@en ;
  schema:url <https://onco.cc/key-papers/paper-monarche-jco-2020/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=monarchE+abemaciclib+adjuvant+Johnston+2020>, <https://clinicaltrials.gov/study/NCT03155997> ;
  schema:sameAs <https://doi.org/10.1200/JCO.20.02514> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Johnston SRD, Harbeck N, Hegg R, et al." ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/cdk46-inhibitor/>, <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:targets <https://onco.cc/targets/cdk4-6/>, <https://onco.cc/targets/estrogen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/abemaciclib/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> ;
  onco:terms <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/hazard-ratio/> ;
  onco:trials <https://onco.cc/trials/monarche/>, <https://onco.cc/trials/natalee/> ;
  onco:people <https://onco.cc/people/miguel-martin/>, <https://onco.cc/people/shao-zhi-ming/>, <https://onco.cc/people/sohn-joohyuk/>, <https://onco.cc/people/javier-cortes/>, <https://onco.cc/people/andrew-wardley/>, <https://onco.cc/people/sara-tolaney/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-dormancy-mrd/>, <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> ;
  onco:journals <https://onco.cc/journals/jco/> .